| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 678 | $2.31 | $1,569.26 | +0.1% | -3.8% | -32.3% | |
| Aug 12, 2022 | ORGO Organogenesis Holdings Inc. | Leibowitz Arthur S | Director | Buy | 3,000 | $4.76 | $14,265.00 | +4.4% | -44.3% | -41.4% | |
| Aug 12, 2022 | ORGO Organogenesis Holdings Inc. | Driscoll Michael Joseph | Director | Buy | 5,000 | $4.80 | $24,000.00 | +24.3% | -44.3% | -41.4% | |
| Aug 12, 2022 | NBIX Neurocrine Biosciences Inc | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 21,533 | $105.95 | $2,281,330.91 | -53.3% | +16.7% | -0.4% | |
| Aug 12, 2022 | LLY Eli Lilly & Co | Tai Jackson P | Director | Buy | 656 | $304.19 | $199,548.64 | +1.1% | +19.7% | +72.0% | |
| Aug 11, 2022 | COLL Collegium Pharmaceutical, Inc | Kuhlmann Shirley R.49 | EVP And General Counsel | Sell | 300 | $20.01 | $6,003.00 | -0.2% | +0.1% | +24.9% | |
| Aug 11, 2022 | PLSH Panacea Life Sciences Holdings, Inc. | Wert Lawrence | Director | Buy | 15,000 | $0.13 | $1,960.00 | +0.4% | - | - | |
| Aug 11, 2022 | LNTH Lantheus Holdings, Inc. | Niedzwiecki Daniel54 | See Remarks | Sell | 3,000 | $82.66 | $247,980.00 | -4.2% | -33.0% | -17.2% | |
| Aug 11, 2022 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Director | Sell | 70,000 | $11.78 | $824,600.00 | -11.8% | -1.4% | -12.8% | |
| Aug 10, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 28,437 | $31.22 | $887,803.14 | -3.7% | +9.8% | +0.6% | |
| Aug 10, 2022 | LLY Eli Lilly & Co | Weems Alonzo | SVP, Erm &Ceco | Sell | 656 | $304.50 | $199,752.00 | -7.5% | +20.8% | +72.2% | |
| Aug 9, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 39,431 | $31.15 | $1,228,275.65 | -5.2% | +11.9% | -1.6% | |
| Aug 9, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 10,000 | $38.35 | $383,500.00 | -9.1% | -6.1% | +94.0% | |
| Aug 9, 2022 | DVAX Dynavax Technologies Corp | Spencer Ryan | CEO And Director | Sell | 14,921 | $16.92 | $252,399.16 | -9.4% | -26.1% | -15.6% | |
| Aug 9, 2022 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 8,055 | $38.38 | $309,145.00 | -6.1% | -6.1% | +94.0% | |
| Aug 9, 2022 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 47,477 | $11.68 | $554,437.91 | -4.0% | -0.7% | -18.8% | |
| Aug 9, 2022 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 26,250 | $16.92 | $444,037.13 | -33.0% | -26.1% | -15.6% | |
| Aug 9, 2022 | DVAX Dynavax Technologies Corp | Janssen Robert71 | Senior Vice President | Sell | 7,938 | $16.92 | $134,276.83 | -18.3% | -26.1% | -15.6% | |
| Aug 8, 2022 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 9,432 | $79.69 | $751,658.05 | -0.5% | -28.9% | -11.1% | |
| Aug 8, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 117,907 | $31.46 | $3,709,402.52 | -7.7% | +11.0% | +5.2% | |
| Aug 8, 2022 | DVAX Dynavax Technologies Corp | Burgess Justin60 | Chief Accounting Officer | Sell | 18,672 | $16.72 | $312,195.84 | -82.9% | -27.9% | -14.6% | |
| Aug 8, 2022 | DVAX Dynavax Technologies Corp | Cano Francis | Director | Sell | 15,000 | $17.17 | $257,550.00 | -41.9% | -27.9% | -14.6% | |
| Aug 8, 2022 | DVAX Dynavax Technologies Corp | Janssen Robert71 | Senior Vice President | Sell | 5,350 | $17.14 | $91,676.19 | -9.8% | -27.9% | -14.6% | |
| Aug 5, 2022 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.60 | President And CEO | Buy | 8,606 | $5.80 | $49,950.08 | +4.5% | +38.9% | -73.3% | |
| Aug 5, 2022 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $16.00 | $320,000.00 | -27.3% | -32.9% | -12.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.